
Oncotelic Therapeutics Advances AI-Powered GMP Manufacturing Platform with TechForce Robotics
Oncotelic Therapeutics completes key Phase 2 objectives in its manufacturing automation initiative, advancing commercialization of an AI-powered GMP platform that integrates proprietary PDAOAI technology with autonomous robotics to transform pharmaceutical manufacturing.
Read full story




















